You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Details for New Drug Application (NDA): 050803


✉ Email this page to a colleague

« Back to Dashboard


NDA 050803 describes VELTIN, which is a drug marketed by Almirall and is included in one NDA. It is available from one supplier. Additional details are available on the VELTIN profile page.

The generic ingredient in VELTIN is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.
Summary for 050803
Tradename:VELTIN
Applicant:Almirall
Ingredient:clindamycin phosphate; tretinoin
Patents:0
Suppliers and Packaging for NDA: 050803
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VELTIN clindamycin phosphate; tretinoin GEL;TOPICAL 050803 NDA AUTHORIZED GENERIC Prasco Laboratories 66993-959 66993-959-31 1 TUBE in 1 CARTON (66993-959-31) / 30 g in 1 TUBE
VELTIN clindamycin phosphate; tretinoin GEL;TOPICAL 050803 NDA AUTHORIZED GENERIC Prasco Laboratories 66993-959 66993-959-61 1 TUBE in 1 CARTON (66993-959-61) / 60 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength1.2%;0.025%
Approval Date:Jul 16, 2010TE:AB2RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.